RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Wayne W. Harding to Receptors, Dopamine

This is a "connection" page, showing publications Wayne W. Harding has written about Receptors, Dopamine.
Connection Strength

2.011
  1. Namballa HK, Decker AM, Dorogan M, Gudipally A, Goclon J, Harding WW. Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity. Bioorg Chem. 2023 12; 141:106862.
    View in: PubMed
    Score: 0.909
  2. Madapa S, Gadhiya S, Kurtzman T, Alberts IL, Ramsey S, Reith M, Harding WW. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands. Eur J Med Chem. 2017 Jan 05; 125:255-268.
    View in: PubMed
    Score: 0.560
  3. Gadhiya S, Madapa S, Kurtzman T, Alberts IL, Ramsey S, Pillarsetty NK, Kalidindi T, Harding WW. Tetrahydroprotoberberine alkaloids with dopamine and s receptor affinity. Bioorg Med Chem. 2016 May 01; 24(9):2060-71.
    View in: PubMed
    Score: 0.542
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support